16-89183555-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000289746.3(CDH15):c.365C>T(p.Ala122Val) variant causes a missense change. The variant allele was found at a frequency of 0.000139 in 1,614,124 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A122P) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000289746.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH15 | NM_004933.3 | c.365C>T | p.Ala122Val | missense_variant | 4/14 | ENST00000289746.3 | NP_004924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH15 | ENST00000289746.3 | c.365C>T | p.Ala122Val | missense_variant | 4/14 | 1 | NM_004933.3 | ENSP00000289746 | P1 | |
CDH15 | ENST00000521087.5 | n.1196C>T | non_coding_transcript_exon_variant | 3/3 | 5 | |||||
CDH15 | ENST00000524089.1 | n.430C>T | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000604 AC: 92AN: 152226Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000196 AC: 49AN: 250190Hom.: 1 AF XY: 0.000126 AC XY: 17AN XY: 135436
GnomAD4 exome AF: 0.0000903 AC: 132AN: 1461780Hom.: 0 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727180
GnomAD4 genome AF: 0.000604 AC: 92AN: 152344Hom.: 1 Cov.: 32 AF XY: 0.000550 AC XY: 41AN XY: 74504
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2017 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CDH15 p.Ala122Val variant was identified in 1 of 1294 proband chromosomes (frequency: 0.00077) from unrelated individuals with mild to severe intellectual disability and was not identified in 1600 control chromosomes from healthy individuals (Bhalla_2008_PMID:19012874). The variant was also identified in dbSNP (ID: rs121434541) and ClinVar (classified as pathogenic by OMIM) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 65 of 281588 chromosomes (1 homozygous) at a frequency of 0.000231 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 59 of 24942 chromosomes (freq: 0.002365), Latino in 5 of 35422 chromosomes (freq: 0.000141) and Other in 1 of 7216 chromosomes (freq: 0.000139), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish) or South Asian populations. Mouse L-cells transfected with CDH15 cDNA containing the A122V change demonstrated a greater than 80% decrease in cell-cell adhesion compared to cells transfected with wildtype CDH15 (Bhalla_2008_PMID:19012874). The p.Ala122 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Intellectual disability, autosomal dominant 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2008 | - - |
CDH15-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at